Cancer Causes & Control

, Volume 23, Issue 11, pp 1811–1819 | Cite as

NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution

  • Bruno Alves de Aguiar Gonçalves
  • Gisele M. Vasconcelos
  • Luiz Claudio Santos Thuler
  • Camilla Andrade
  • Alessandra Faro
  • Maria S. Pombo-de-OliveiraEmail author
  • Brazilian Collaborative Study Group of Infant Acute Leukemia
Original paper



The risk of developing childhood leukemia has been associated with gene polymorphisms that decrease the activity of detoxifying metabolic enzymes and enzymes involved in systemic oxidative stress. We investigated the NQO1 and PON1 polymorphisms for associations with susceptibility to childhood leukemia.


Samples from 1,027 Brazilian children (519 acute lymphoblastic leukemia, ALL; 107 acute myeloid leukemia, AML; 401 controls) were analyzed. TaqMAN real-time assays were used to determine the NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) frequencies. Logistic regression was used to evaluate the association of polymorphisms with cases and controls, with age and somatic fusion genes (MLL-r and ETV6-RUNX1) as covariables.


Children with at least one NQO1 variant allele were at lower risk for developing infant AML (odds ratio (OR) 0.26, 95 % confidence interval (CI) 0.10–0.68); no association was detected for ALL. PON1 rs854560 (L55M) was associated with an increased risk of developing childhood leukemia (LM + MM, OR 1.93, 95 % CI 1.32–2.81). The PON1 rs662 R192R genotype had a statistically significant decreased frequency in ALL (OR 0.64, 95 % CI 0.43–0.93). Infant ALL cases were more likely to harbor homozygous PON1 rs854560 alleles than controls (OR 1.72, 95 % CI 1.03–2.89); at least one M allele was associated with an increased risk of ALL in children older than 1 year (OR 1.99, 95 % CI 1.17–3.3).


The NQO1 rs1800566 (C609T), PON1 rs854560 (L55M), and PON1 rs662 (Q192R) polymorphisms modified risk depending on leukemia subtype (decreased in AML, increased and decreased in ALL, respectively), age strata, and variant genotype combinations.


Infant leukemia Acute lymphoblastic leukemia NQO1 PON1 Polymorphisms 



This investigation was supported by the Brazilian National Research Council (CNPq), Instituto Nacional de Câncer and Fundação do Cancer Ary Frauzino. MSPO is supported by CNPq research scholarship #309091/2007. The project was granted by INCT-Controle do Cancer; CNPq #573806/2008-0 and FAPERJ E026/2008. We thank Dr. Davy Rapozo for helping with the setup of the technical procedures. We are grateful to Dr. Joseph L. Wiemels for helpful comments and reviewing the manuscript.

Supplementary material

10552_2012_60_MOESM1_ESM.doc (48 kb)
Supplementary material 1 (DOC 48 kb)
10552_2012_60_MOESM2_ESM.doc (44 kb)
Supplementary material 2 (DOC 44 kb)
10552_2012_60_MOESM3_ESM.doc (39 kb)
Supplementary material 3 (DOC 39 kb)


  1. 1.
    Belson M, Kingsley B, Holmes A (2007) Risk factors for acute leukemia in children: a review. Environ Health Perspect 115:138–145PubMedCrossRefGoogle Scholar
  2. 2.
    Greaves M (1999) Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 35:1941–1953PubMedCrossRefGoogle Scholar
  3. 3.
    Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97:230–236PubMedCrossRefGoogle Scholar
  4. 4.
    Bolufer P, Barragan E, Collado M, Cervera J, Lopez JA, Sanz MA (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30:1471–1491PubMedCrossRefGoogle Scholar
  5. 5.
    Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639–649PubMedCrossRefGoogle Scholar
  6. 6.
    Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL (1996) Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children’s Cancer Group. Cancer Causes Control 7:581–590PubMedCrossRefGoogle Scholar
  7. 7.
    Alexander FE, Patheal SL, Biondi A et al (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61:2542–2546PubMedGoogle Scholar
  8. 8.
    Pombo-de-Oliveira MS, Koifman S et al (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 15:2336–2341PubMedCrossRefGoogle Scholar
  9. 9.
    Greaves M (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6:193–203PubMedCrossRefGoogle Scholar
  10. 10.
    Simpson J, Smith A, Ansell P, Roman E (2007) Childhood leukaemia and infectious exposure: a report from the United Kingdom Childhood Cancer Study (UKCCS). Eur J Cancer 43:2396–2403PubMedCrossRefGoogle Scholar
  11. 11.
    Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S et al. (2011) Pregnancy, exposure to pesticides and infant leukemia in Brazil. Environ Health Perspect. doi:
  12. 12.
    Vasiliou V, Ross D, Nebert DW (2006) Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2:329–335PubMedCrossRefGoogle Scholar
  13. 13.
    Rothman N, Smith MT, Hayes RB et al (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C- > T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57:2839–2842PubMedGoogle Scholar
  14. 14.
    Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550PubMedCrossRefGoogle Scholar
  15. 15.
    Cole TB, Jampsa RL, Walter BJ et al (2003) Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357–364PubMedCrossRefGoogle Scholar
  16. 16.
    Smith MT, Wang Y, Skibola CF, et al. (2002) Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 100:4590–4593Google Scholar
  17. 17.
    Perera FP (1999) Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 107(Suppl 3):451–460PubMedCrossRefGoogle Scholar
  18. 18.
    Huen K, Harley K, Brooks J et al (2009) Developmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphisms. Environ Health Perspect 117:1632–1638PubMedGoogle Scholar
  19. 19.
    Pombo de Oliveira MS, Koifman S, Vasconcelos GM, Emerenciano M et al (2009) Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia. Blood Cells Mol Dis 42:121–125PubMedCrossRefGoogle Scholar
  20. 20.
    So CWE (2009) Leukemia Methods and Protocols. Methods in molecular biology. Humana, London, pp 538–544Google Scholar
  21. 21.
    Pena SD, Di Pietro G, Fuchshuber-Moraes M et al (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS ONE 6(2):e17063PubMedCrossRefGoogle Scholar
  22. 22.
    Rios DL, D’Onofrio LO, Cerqueira CC et al (2007) Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians. Clin Chem Lab Med 45:874–878PubMedCrossRefGoogle Scholar
  23. 23.
    da Silva Silveira V, Canalle R, Scrideli CA et al (2009) Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 33:898–901CrossRefGoogle Scholar
  24. 24.
    Kracht T, Schrappe M, Strehl S et al (2004) NQO1 C607T polymorphism in distinct entities of pediatric hematological neoplasms. Haematologica 89:1492–1497PubMedGoogle Scholar
  25. 25.
    Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF (1999) A lack of a functional NAD(P)H: quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 59:4095–4099PubMedGoogle Scholar
  26. 26.
    Sirma S, Agaoglu L, Yildiz I et al (2004) NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 43:568–570PubMedCrossRefGoogle Scholar
  27. 27.
    Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA (2008) NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 168:1221–1232PubMedCrossRefGoogle Scholar
  28. 28.
    Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG (2002) NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4:62–70PubMedCrossRefGoogle Scholar
  29. 29.
    Gaikwad NW, Rogan EG, Cavalieri EL (2007) Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 43:1289–1298PubMedCrossRefGoogle Scholar
  30. 30.
    Buffler PA, Gunier RB, Dahl G, Smith MT, Reinier K, Reynolds P (2002) Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect 110:955–960PubMedCrossRefGoogle Scholar
  31. 31.
    Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T (2007) Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Chem Biol Interact 168:184–192PubMedCrossRefGoogle Scholar
  32. 32.
    Nielsen SS, Mueller BA, De Roos AJ, Viernes HMA, Farin FM, Checkoway H (2005) Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1). Environ Health Perspect 113:909–913CrossRefGoogle Scholar
  33. 33.
    Martínez C, Molina JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Agúndez JA, García-Martín E (2010) Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol 19:10Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Bruno Alves de Aguiar Gonçalves
    • 1
  • Gisele M. Vasconcelos
    • 1
  • Luiz Claudio Santos Thuler
    • 2
  • Camilla Andrade
    • 1
  • Alessandra Faro
    • 1
  • Maria S. Pombo-de-Oliveira
    • 1
    Email author
  • Brazilian Collaborative Study Group of Infant Acute Leukemia
  1. 1.Pediatric Hematology-Oncology Program, Research CenterInstituto Nacional de CâncerRio de JaneiroBrazil
  2. 2.Clinical Research, Research CenterInstituto Nacional de CâncerRio de JaneiroBrazil

Personalised recommendations